SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-031880
Filing Date
2020-07-07
Accepted
2020-07-07 06:50:41
Documents
14
Period of Report
2020-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K reta-8k_20200707.htm   iXBRL 8-K 40068
2 EX-99.1_PR reta-ex991_6.htm EX-99.1 21718
3 GRAPHIC gkx1p3qjrpfi000001.jpg GRAPHIC 6766
  Complete submission text file 0001564590-20-031880.txt   203790

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA reta-20200707.xsd EX-101.SCH 5772
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20200707_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20200707_pre.xml EX-101.PRE 11174
7 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20200707_htm.xml XML 3428
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 201015213
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences